Skip to main content

Eversept Partners, LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1697013 NEW YORK, NY

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,656,530
-$10,282,556 QoQ
Shares Held
1,865,653
-38.6% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#33
of 316 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $209,186,993 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BCRX
Biocryst Pharmaceuticals Inc
This page
1,865,653 $18,656,530

All Filings in BCRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,656,530 1,865,653
2026-03-31 $28,939,086 3,039,820
2025-12-31 $23,344,581 2,992,895
2025-09-30 $10,425,813 1,373,625
2025-06-30 $10,820,436 1,207,638
2025-03-31 $16,293,270 2,172,436
2024-12-31 $14,891,946 1,980,312
2024-09-30 $4,069,078 535,405
2024-06-30 $7,122,901 1,152,573
2024-03-31 $7,276,729 1,432,427
2023-12-31 $9,158,991 1,529,047
2023-09-30 $17,552,049 2,479,103
2023-06-30 $16,699,675 2,372,113
2023-03-31 $37,702,838 4,520,724
2022-12-31 $10,107,990 880,487
2020-12-31 $3,664,297 491,852
2020-09-30 $3,932,645 1,143,211
2020-06-30 $23,075,489 4,847,792
2020-03-31 $15,084,744 7,542,372